Gabriel Kristian Pedersen

Gabriel Kristian Pedersen

Kontakt

Gabriel Kristian Pedersen, Afsnitsleder, Afdeling for Infektionsimmunologi / Adjuvans
@. gakp@ssi.dk

Forskningsområder

Jeg forsker i, hvordan adjuvanser kan hjælpe vacciner til at yde optimal beskyttelse. Dette inkluderer:

  • Undersøge hvordan forskellige vaccineadjuvanser virker
  • Udvikle nye adjuvanssystemer
  • Vaccinedesign og undersøgelse af hvilke adjuvanser som er bedst egnet ift. forskellige vaccinationsområder

Ansvarsområder

  • Afsnitsleder for Vaccineadjuvanser, Afdeling for Infektionsimmunologi

Udvalgte publikationer

  • Pedersen GK, Andersen P, Christensen D. 2018. Immunocorrelates of CAF family adjuvants. Semin Immunol 39: 4-13
  • Wilkinson A, Lattmann E, Roces CB, Pedersen GK, Christensen D, Perrie Y. 2018. Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01. J Control Release 291:1-10
  • Schmidt ST, Pedersen GK, Neustrup MA, Korsholm KS, Rades T, Andersen P, Foged C, Christensen D. 2018. Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C). Front Immunol 9:898
  • Pedersen GK, Li X, Khoenkhoen S, Ádori M, Beutler B, Karlsson Hedestam GB. 2018. B-1a Cell Development in Splenectomized Neonatal Mice. Front Immunol 9:1738
  • Pedersen GK, Àdori M, Khoenkhoen S, Dosenovic P, Beutler B, Karlsson Hedestam GB. 2014. B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS. PNAS 111:E4119-26